90 related articles for article (PubMed ID: 17398269)
1. The influence of HRT on technical recall in the UK Breast Screening Programme: are pain, compression force, and compressed breast thickness contributing factors?
Nimmo LJ; Alston LA; McFadyen AK
Clin Radiol; 2007 May; 62(5):439-46. PubMed ID: 17398269
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.
Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M; Patnick J
Breast Cancer Res; 2006; 8(1):R8. PubMed ID: 16417651
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
Crouchley K; Wylie E; Khong E
J Med Screen; 2006; 13(2):93-7. PubMed ID: 16792833
[TBL] [Abstract][Full Text] [Related]
4. Influence of hormone replacement therapy on the accuracy of screening mammography.
Vernet Mdel M; Checa MA; Macià F; Casamitjana M; Carreras R
Breast J; 2006; 12(2):154-8. PubMed ID: 16509841
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and accuracy of mammographic screening.
Kavanagh AM; Mitchell H; Giles GG
Lancet; 2000 Jan; 355(9200):270-4. PubMed ID: 10675074
[TBL] [Abstract][Full Text] [Related]
6. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme.
Litherland JC; Evans AJ; Wilson AR
Clin Radiol; 1997 Apr; 52(4):276-9. PubMed ID: 9112944
[TBL] [Abstract][Full Text] [Related]
7. Predictors of outcome of mammography in the National Health Service Breast Screening Programme.
Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M
J Med Screen; 2002; 9(2):74-82. PubMed ID: 12133927
[TBL] [Abstract][Full Text] [Related]
8. Influence of menopausal status and use of hormone replacement therapy on radiation dose from mammography in routine breast screening.
Whitaker CJ; Kelly CM; Faulkner K; Stamp EC
Br J Radiol; 2006 Jul; 79(943):597-602. PubMed ID: 16823065
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhône programme.
Séradour B; Estève J; Heid P; Jacquemier J
J Med Screen; 1999; 6(2):99-102. PubMed ID: 10444729
[TBL] [Abstract][Full Text] [Related]
10. Duration of hormone replacement therapy, breast tumour size and grade in a screening programme.
Gertig DM; Erbas B; Fletcher A; Amos A; Kavanagh AM
Breast Cancer Res Treat; 2003 Aug; 80(3):267-73. PubMed ID: 14503799
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.
Azam S; Lange T; Huynh S; Aro AR; von Euler-Chelpin M; Vejborg I; Tjønneland A; Lynge E; Andersen ZJ
Cancer Causes Control; 2018 Jun; 29(6):495-505. PubMed ID: 29671181
[TBL] [Abstract][Full Text] [Related]
12. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
Séradour B; Allemand H; Weill A; Ricordeau P
Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
[TBL] [Abstract][Full Text] [Related]
13. Do women taking hormone replacement therapy (HRT) have a higher incidence of breast cancer than women who do not?
Fleming RM
Integr Cancer Ther; 2003 Sep; 2(3):235-7. PubMed ID: 15035886
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
15. [Impact of replacement hormone therapy in menopause on breast radiologic density and possible complications of mammography in the assessment of breast masses].
Ciatto S; Bonardi R; Zappa M
Radiol Med; 2001; 101(1-2):39-43. PubMed ID: 11360750
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
Olsson HL; Ingvar C; Bladström A
Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review.
Banks E
J Med Screen; 2001; 8(1):29-34. PubMed ID: 11373847
[TBL] [Abstract][Full Text] [Related]
18. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal replacement therapy and breast cancer].
This P
Rev Prat; 2005 Feb; 55(4):377-82. PubMed ID: 15828615
[TBL] [Abstract][Full Text] [Related]
20. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]